Scarica l'app Stockscreener
1.34
2.29%
0.03
Dopo l'orario di chiusura:
1.34
Precedente Chiudi:
$1.31
Aprire:
$1.29
Volume 24 ore:
40,564
Relative Volume:
0.39
Capitalizzazione di mercato:
$46.07M
Reddito:
-
Utile/perdita netta:
$-10.41M
Rapporto P/E:
-3.9869
EPS:
-0.3361
Flusso di cassa netto:
$-3.69M
1 W Prestazione:
+0.75%
1M Prestazione:
+1.52%
6M Prestazione:
-22.54%
1 anno Prestazione:
-48.85%
Intervallo 1D:
$1.28
$1.34
Intervallo di 1 settimana:
$1.14
$1.36
Portata 52W:
$1.05
$3.10
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Nome
Telomir Pharmaceuticals Inc
Settore
Industria
Telefono
786-396-6723
Indirizzo
100 SE 2ND ST, MIAMI
Compare TELO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.34 | 45.04M | 0 | -10.41M | -3.69M | -0.3361 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-21 | Iniziato | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie
Sentiment Review: Will Telomir Pharmaceuticals Inc outperform small cap indexesPortfolio Risk Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Wrap: How does Telomir Pharmaceuticals Inc compare to its peers2026 Intraday Action & Fast Moving Stock Trade Plans - baoquankhu1.vn
TELO SEC FilingsTelomir Pharms 10-K, 10-Q, 8-K Forms - Stock Titan
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer - ACCESS Newswire
Telomir Pharmaceuticals submits IND in U.S. for Telomir-1 in TNBC - BioWorld News
Telomir Pharmaceuticals Regains Nasdaq Compliance Following 2025 Annual Shareholders Meeting - Minichart
Telomir submits IND application for cancer drug candidate By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance - TipRanks
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) Targeting Advanced Triple-Negative Breast Cancer - Minichart
Telomir Pharmaceuticals Submits IND for Telomir-1 in Advanced Triple-Negative Breast Cancer - National Today
Telomir Pharmaceuticals regains Nasdaq compliance after annual meeting - Investing.com
Nasdaq confirms Telomir (NASDAQ: TELO) back in listing compliance - Stock Titan
Telomir submits IND application for cancer drug candidate - Investing.com
Telomir takes experimental TNBC therapy to FDA for metastatic disease - Stock Titan
Telomir Pharmaceuticals submits IND application to FDA for Telomir-1 in TNBC By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals submits IND application to FDA for Telomir-1 in TNBC - Investing.com
Telomir submits IND for Telomir-1 to treat advanced and metastatic TNBC - TradingView
Telomir Pharmaceuticals (NASDAQ: TELO) files IND for Telomir-1 in advanced TNBC - Stock Titan
Telomir Shareholders Approve Equity Plan and Bylaw Changes - The Globe and Mail
Pullback Watch: Is Telomir Pharmaceuticals Inc stock a buy or sell2026 Weekly Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
Telomir Pharmaceuticals 2026 Annual Meeting Results: Shareholder Votes, Amended Bylaws, and Incentive Plan Approval - Minichart
Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development - Bluffton Today
Telomir Pharmaceuticals, Inc. unveils Telomir-1 for cellular dysfunction targeting iron and zinc balance - Traders Union
Telomir Pharmaceuticals shareholders approve acquisition and bylaw changes - Investing.com UK
Telomir Pharmaceuticals (NASDAQ: TELO) clears Teli deal and expands equity incentive plan - Stock Titan
Pharma News: Should I trade or invest in Telomir Pharmaceuticals Inc2026 Earnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models - ACCESS Newswire
Setup Watch: Is Telomir Pharmaceuticals Inc a cyclical or defensive stockMarket Trend Summary & Community Trade Idea Sharing Platform - baoquankhu1.vn
CEO Moves: Is Telomir Pharmaceuticals Inc stock good for income investors2026 Stock Rankings & Risk Managed Investment Signals - baoquankhu1.vn
Telomir Pharmaceuticals, Inc.: Preclinical Pipeline Targeting Aging and Age-Related Diseases with Novel Small-Molecule Therapeutics - Minichart
Insider Buy: How does Telomir Pharmaceuticals Inc score in quality rankingsMarket Rally & Real-Time Volume Triggers - baoquankhu1.vn
Telomir Pharmaceuticals 2025 10-K: $0 Revenue, $(0.33) EPS on $(10.41)M Net Loss - TradingView
Telomir Pharmaceuticals (NASDAQ: TELO) details 2025 results, Telomir-1 plans and TELI merger - Stock Titan
US Market Recap: Will Unisys Corporation stock go up in YEAR2026 Short Interest & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Telomir Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Winners Losers: Is Telomir Pharmaceuticals Inc a top pick in the sectorTrade Risk Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Risk Analysis: Can Genco Shipping Trading Limited be recession proofWall Street Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Trading Action: Is Telomir Pharmaceuticals Inc. a good ESG investmentQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Portfolio Recap: Will Telomir Pharmaceuticals Inc outperform small cap indexesJuly 2025 Update & Entry Point Confirmation Signals - baoquankhu1.vn
Nasdaq Moves: Is Telomir Pharmaceuticals Inc a good ESG investment2025 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
TELO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TELO Technical Analysis & ETF Price Forecast - Intellectia AI
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Activity Recap: Is Telomir Pharmaceuticals Inc stock influenced by commodity pricesCPI Data & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Valuation Update: What are the risks of holding Telomir Pharmaceuticals IncJuly 2025 Selloffs & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Telomir Pharmaceuticals Faces Crucial Corporate and Regulatory Deadlines () - aktiencheck.de
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Rating Upgraded by Wall Street Zen - Defense World
Is Telomir Pharmaceuticals Inc. stock a good dividend stockJuly 2025 Gainers & Verified Chart Pattern Signals - mfd.ru
Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 4.2% – Should You Sell? - Defense World
Telomir Sets Vote on Transformative TELI Merger and Governance Changes - The Globe and Mail
Telomir reveals promising preclinical data for Telomir-Zn - TipRanks
Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):